Will Viking Therapeutics Get Acquired?
The Motley Fool
MARCH 16, 2024
Investors have become excited about the company's long-term prospects, as it has a promising weight-loss drug in its portfolio. Viking's balance sheet looks strong While Viking has an exciting asset in its portfolio, the numbers still have to work for a prospective buyer. And its total liabilities were just $20 million.
Let's personalize your content